UNSPSC 51171602: Docusate calcium

This classification denotes a stool softener, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F05Q2T2JA0. European Medicines Agency schedules Docusate sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06348MIG. Docusate sodium generally arises in the molecular formula C20H37NAO7S. The term 'docusate sodium' is an International Nomenclature of Cosmetic Ingredients designation. As of Q4 2014, DOCUSATE CALCIUM remains the US FDA Preferred Term for this commodity.

Docusate calcium bears US NLM identifiers UMLS ID C0282140 and NCI Concept Code C28999. SMILES: S(=O)(=O)(O)C(CC(=O)OCC(CCCC)CC)C(=O)OCC(CCCC)CC.[NA].

UNSPSC 51171602 Docusate calcium is a Commodity code that in recent state and local procurement shows little activity aligned with its nominal pharmaceutical scope. The single recent opportunity tagged under this code—Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services—does not involve docusate calcium or any pharmaceutical product. The solicitation calls for staffing of two drug-testing collection sites in Plano and McKinney, operation of a randomized testing notification system, immunoassay and confirmatory laboratory screening with LC/MS/MS or GC/MS, and alternative testing methodologies including oral fluid and hair analysis. Lab certification from SAMHSA, Texas DPS, or CAP is required. The estimated contract value is $600,000 over a two-year base term with three optional one-year renewals, with pricing structured per test across three service models: screening only, confirmation after screening, and screening with automatic confirmation of positives. Evaluation weighting includes vendor understanding (30 points), firm qualifications (25 points), client references (15 points), cost (30 points), and optional demonstrations and interviews (up to 30 points). This is a county-level issuing body, and the contract is funded through the Texas Department of Criminal Justice-Community Justice Assistance Division.

The recent activity shows concentration in Texas, specifically Collin County. The RFP 2026-327 response deadline was July 23, 2026, with an anticipated award date of August 10, 2026. No other state or local opportunities under this code appear in the recent record. The mismatch between the code's pharmaceutical designation and the actual work being solicited—criminal justice specimen collection and drug testing—suggests either a data-entry error in the source records or misalignment between the UNSPSC taxonomy applied and the services actually being procured. Business development professionals should treat this code as showing minimal relevant recent activity.